Henderson A F, Heaton R W, Costello J F
Thorax. 1983 Jul;38(7):512-5. doi: 10.1136/thx.38.7.512.
The effect of nifedipine (20 mg sublingually) on the bronchial response to cold air was studied in eight asthmatic patients and eight normal subjects. Eucapnic hyperventilation with dry subfreezing air was performed for three minutes by each subject, with a minute volume of 30 X FEV1 for normal subjects and half that for the asthmatics. In the normal subjects there was no difference in the falls in the one-second forced expiratory volume (FEV1) and specific airways conductance (sGaw) produced by cold air inhalation on the days when they were pretreated with placebo and with nifedipine. In asthmatic patients, however, significant protection with nifedipine was demonstrated. The maximum recorded fall in FEV1 was reduced from 13% +/- 2% (SE) to 4% +/- 2% (p less than 0.005) and the maximum fall in sGaw from 35% +/- 5% to 17% +/- 4% (p less than 0.002). The possible causes of this difference are discussed. It is suggested that these results present further evidence for a different mechanism of response to cold air in asthmatic and normal subjects.
在8例哮喘患者和8名正常受试者中研究了硝苯地平(20mg舌下含服)对支气管冷空气反应的影响。每位受试者用低于冰点的干燥空气进行3分钟的等碳酸过度通气,正常受试者每分通气量为30×第一秒用力呼气量(FEV1),哮喘患者为正常受试者的一半。在正常受试者中,吸入冷空气前用安慰剂和硝苯地平预处理时,吸入冷空气后一秒用力呼气量(FEV1)和比气道传导率(sGaw)下降情况无差异。然而,在哮喘患者中,硝苯地平显示出显著的保护作用。记录到的FEV1最大下降率从13%±2%(标准误)降至4%±2%(P<0.005),sGaw最大下降率从35%±5%降至17%±4%(P<0.002)。讨论了这种差异的可能原因。提示这些结果为哮喘患者和正常受试者对冷空气反应的不同机制提供了进一步证据。